Literature DB >> 21331894

Indinavir resistance evolution: a comment.

Viroj Wiwanitkit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21331894      PMCID： PMC8222451          DOI： 10.1007/s12250-011-3173-6

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  4 in total

1.  HIV-1 protease mutations and protease inhibitor cross-resistance.

Authors:  Soo-Yon Rhee; Jonathan Taylor; W Jeffrey Fessel; David Kaufman; William Towner; Paolo Troia; Peter Ruane; James Hellinger; Vivian Shirvani; Andrew Zolopa; Robert W Shafer
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

2.  Indinavir resistance evolution in one human immunodeficiency virus type 1 infected patient revealed by single-genome amplification.

Authors:  Qing-Mao Geng; Han-Ping Li; Zuo-Yi Bao; Yong-Jian Liu; Dao-Min Zhuang; Lin Li; Si-Yang Liu; Jing-Yun Li
Journal:  Virol Sin       Date:  2010-10-08       Impact factor: 4.327

3.  Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay.

Authors:  Ju-yeon Choi; Oh-Kyung Kwon; Seon Young Choi; Yong Keun Park; Sung Soon Kim
Journal:  J Clin Virol       Date:  2010-10-20       Impact factor: 3.168

4.  Single-molecule sequencing of an individual human genome.

Authors:  Dmitry Pushkarev; Norma F Neff; Stephen R Quake
Journal:  Nat Biotechnol       Date:  2009-08-10       Impact factor: 54.908
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.